---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-030203"
form_type: "8-K"
ticker: "FDMT"
cik: "0001650648"
company_name: "4D Molecular Therapeutics, Inc."
filed_at: "2024-02-09T23:59:59+00:00"
generated_at: "2026-06-06T04:51:37.026861+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# 4D Molecular Therapeutics raises ~$281.4M in public offering of common stock and pre-funded warrants

## Summary
- Sold 6,586,015 shares at $29.50/share and pre-funded warrants for 3,583,476 shares at $29.4999 each.
- Underwriters granted 30-day option to purchase up to 1,525,423 additional shares.
- Net proceeds ~$281.4M after underwriting discounts and expenses; offering closed Feb 9, 2024.
- Directors and officers subject to lock-up until April 6, 2024 without underwriter consent.

## SEC filing metadata
- accession: 0001193125-24-030203
- form_type: 8-K
- ticker: FDMT
- cik: 0001650648
- company_name: 4D Molecular Therapeutics, Inc.
- filed_at: 2024-02-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650648/000119312524030203/0001193125-24-030203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650648/000119312524030203/d185041d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-030203
- JSON: https://secwatch.observer/filing/0001193125-24-030203.json
- Plain text: https://secwatch.observer/filing/0001193125-24-030203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.